Our approach to climate action
Our operational emissions goal has been validated by the Science-Based Targets initiative (SBTi) as being consistent with the reductions required to keep global warming to 1.5°C.
We are also proud signatories of the Race to Zero/ Business Ambition for 1.5 campaign and have an ambition to achieve net zero carbon emissions across our value chain by 2045.
Specifically, we are committed1 to:
Advancing renewable electricity
100% renewable electricity in Europe
This achievement comes thanks to three deals that led to the construction of two new wind farms and one new solar field in Spain, adding to our existing on-site and off-site electricity projects.
*Johnson & Johnson property sites larger than 50,000 ft2 where the company has operational control
Delivering energy efficiency
Tapping into new energy sources
Our renewable electricity footprint*
Our value chain
Enabling our suppliers
Collaborating for greater impact
In 2022, we announced a new collaboration called Activate, bringing together five pharmaceutical companies to support active pharmaceutical ingredient (API) suppliers in their decarbonization efforts.
Our commitment to energy leadership
Established formal energy management program
Established first enterprise-wide public commitment to reduce CO2 emissions based on Kyoto Protocol
Developed internal CO2 capital relief program, which has resulted in 231 projects and 288,000 metric tons of CO2 saved per year over the past 15 years
Announced goal to reduce CO2 emissions by 20% by 2020 and increase on-site clean energy capacity to 50MW by 2015. Currently over 50 solar arrays and 4 wind turbines built, totaling 56MWs on our properties globally
Supported the UNFCCC Paris Climate agreement and committed to using 100% renewable electricity in our operations by joining RE100. Since then increased our renewable electricity consumption to near 50%
Launched 4th generation science-based climate commitments, accelerating our 100% renewable electricity commitment to 2025, committing to carbon neutrality in our operations and a 20% value chain emissions reduction by 2030
Finalized deals to reach 100% renewable electricity in the U.S., Canada and Europe. Joined Energize with 9 of our peers in the pharmaceutical industry to help increase access to renewable energy within our supply chains
Announced Activate, a collaboration of pharmaceutical companies to support active pharmaceutical ingredient suppliers. Signed contract for 100% renewable electricity in Brazil.
1 Our current climate goals have been validated by the Science-Based Targets initiative (SBTi). We are currently in the process of aligning new climate goals with SBTi that will reflect the recent separation of the Company’s Consumer Health business.
2 Based on current properties owned/leased by Johnson & Johnson within our operational control; Does not include Puerto Rico